BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24535045)

  • 1. Protection of ovarian function by GnRH agonists during chemotherapy: a meta-analysis.
    Sun X; Dongol S; Jiang J; Kong B
    Int J Oncol; 2014 Apr; 44(4):1335-40. PubMed ID: 24535045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent treatment with gonadotropin-releasing hormone agonists for chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a meta-analysis of randomized controlled trials.
    Yang B; Shi W; Yang J; Liu H; Zhao H; Li X; Jiao S
    Breast; 2013 Apr; 22(2):150-157. PubMed ID: 23298851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials.
    Del Mastro L; Ceppi M; Poggio F; Bighin C; Peccatori F; Demeestere I; Levaggi A; Giraudi S; Lambertini M; D'Alonzo A; Canavese G; Pronzato P; Bruzzi P
    Cancer Treat Rev; 2014 Jun; 40(5):675-83. PubMed ID: 24360817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.
    Senra JC; Roque M; Talim MCT; Reis FM; Tavares RLC
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):77-86. PubMed ID: 29055060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors.
    Blumenfeld Z; Zur H; Dann EJ
    Oncologist; 2015 Nov; 20(11):1283-9. PubMed ID: 26463871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of gonadal function in women undergoing chemotherapy: a systematic review and meta-analysis of the potential role for gonadotropin-releasing hormone agonists.
    Hickman LC; Llarena NC; Valentine LN; Liu X; Falcone T
    J Assist Reprod Genet; 2018 Apr; 35(4):571-581. PubMed ID: 29470701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.
    Clowse ME; Behera MA; Anders CK; Copland S; Coffman CJ; Leppert PC; Bastian LA
    J Womens Health (Larchmt); 2009 Mar; 18(3):311-9. PubMed ID: 19281314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.
    Demeestere I; Brice P; Peccatori FA; Kentos A; Dupuis J; Zachee P; Casasnovas O; Van Den Neste E; Dechene J; De Maertelaer V; Bron D; Englert Y
    J Clin Oncol; 2016 Aug; 34(22):2568-74. PubMed ID: 27217453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
    Munhoz RR; Pereira AA; Sasse AD; Hoff PM; Traina TA; Hudis CA; Marques RJ
    JAMA Oncol; 2016 Jan; 2(1):65-73. PubMed ID: 26426573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical approaches to preservation of fertility in female cancer patients.
    Del Mastro L; Giraudi S; Levaggi A; Pronzato P
    Expert Opin Pharmacother; 2011 Feb; 12(3):387-96. PubMed ID: 21254946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.
    Lambertini M; Ceppi M; Poggio F; Peccatori FA; Azim HA; Ugolini D; Pronzato P; Loibl S; Moore HC; Partridge AH; Bruzzi P; Del Mastro L
    Ann Oncol; 2015 Dec; 26(12):2408-19. PubMed ID: 26347105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of hormonal protection for chemotherapy-induced gonadotoxicity.
    Kim SS; Lee JR; Jee BC; Suh CS; Kim SH; Ting A; Petroff B
    Clin Obstet Gynecol; 2010 Dec; 53(4):740-52. PubMed ID: 21048441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women.
    Chen H; Li J; Cui T; Hu L
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008018. PubMed ID: 22071842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin-releasing hormone agonist may minimize premature ovarian failure in young women undergoing autologous stem cell transplantation.
    Blumenfeld Z; Patel B; Leiba R; Zuckerman T
    Fertil Steril; 2012 Nov; 98(5):1266-70.e1. PubMed ID: 22935556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis.
    Elgindy E; Sibai H; Abdelghani A; Mostafa M
    Obstet Gynecol; 2015 Jul; 126(1):187-95. PubMed ID: 26241272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis.
    Bedaiwy MA; Abou-Setta AM; Desai N; Hurd W; Starks D; El-Nashar SA; Al-Inany HG; Falcone T
    Fertil Steril; 2011 Mar; 95(3):906-14.e1-4. PubMed ID: 21145541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'An ounce of prevention is worth a pound of cure': the case for and against GnRH-agonist for fertility preservation.
    Blumenfeld Z; Katz G; Evron A
    Ann Oncol; 2014 Sep; 25(9):1719-1728. PubMed ID: 24651411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial.
    Demeestere I; Brice P; Peccatori FA; Kentos A; Gaillard I; Zachee P; Casasnovas RO; Van Den Neste E; Dechene J; De Maertelaer V; Bron D; Englert Y
    J Clin Oncol; 2013 Mar; 31(7):903-9. PubMed ID: 23129737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R).
    Choi MC; Chung YS; Lee JW; Kwon BS; Park BK; Kim SI; Shim SH; Lee KB; Seong SJ; Lee SJ; Lee SH; Yoo HJ; Song T; Kim MK; Baek MH; Kang S; Kim YM
    Eur J Cancer; 2020 Jul; 133():56-65. PubMed ID: 32442924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-Releasing Hormone Analogs for Gonadal Protection During Gonadotoxic Chemotherapy: A Systematic Review and Meta-Analysis.
    Sofiyeva N; Siepmann T; Barlinn K; Seli E; Ata B
    Reprod Sci; 2019 Jul; 26(7):939-953. PubMed ID: 30270741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.